Advertisement

Search Results

Advertisement



Your search for Michael A. Postow, MD, and Jedd D. Wolchok, MD, PhD matches 1 pages

Showing 1 - 1


skin cancer

Survival Benefits of Front-Line Treatment With Nivolumab for Advanced Melanoma Confirmed, Yet Questions Remain

As reported in this issue of The ASCO Post, Robert and colleagues recently published a phase III study comparing the anti–programmed death 1 (PD-1) antibody nivolumab with the standard melanoma chemotherapy dacarbazine in the front-line treatment of patients with advanced BRAF wild-type melanoma.1...

Advertisement

Advertisement



Advertisement